Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
This clinical trial update describes a long-term observational study assessing the safety and efficacy of FURESTEM-AD Inj. in people with at…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Atopic Dermatitis (AD) and Food Allergy
The NIAID-sponsored clinical trial NCT03168113 investigating Atopic Dermatitis (AD) with non-atopic healthy controls has been completed.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis [Phase 2]
Phase 2a study completed evaluating the efficacy and safety of MEDI9929 in adults with atopic dermatitis.
-
FDA approval · 2018-02-13FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved Betamethasone Dipropionate as an original application from Encube Ethicals, Inc. (ANDA206389) for topical use in inflammatory d…
-
FDA approval · 2018-01-30FDA Approved: CLOBETASOL PROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic clobetasol propionate topical as an Original Application (ANDA). It is indicated for inflammator…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis [Phase 2]
Phase 2 trial update evaluating pharmacodynamics of Omiganan BID in patients with atopic dermatitis completed.
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis [Phase 2]
Phase 2 trial updates for PR022 topical gel in mild-to-moderate atopic dermatitis focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis [Phase 2]
Phase 2 pilot trial evaluating ustekinumab for chronic atopic dermatitis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis [Phase 2]
Phase 2 trial assessing safety, pharmacokinetics, and preliminary efficacy of asimadoline for pruritus in atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled study evaluating topical clobetasone butyrate 0.05% cream for eczema; study status is C…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial results show dupilumab monotherapy used in adults with moderate-to-severe atopic dermatitis; the study has completed with resu…
-
FDA approval · 2017-11-21FDA Approved: HYDROCORTISONE BUTYRATE — Original Application (The J. Molner Company LLC)
The FDA approved a generic topical hydrocortisone butyrate product under an Original Application (ANDA 209556) from The J. Molner Company LL…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) [Phase 2]
Phase 2 dose-finding study of GSK2894512 cream in adults with atopic dermatitis; results from the completed trial have been posted.
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: The Effects of Early Life PUFA and R-TFA on AD: A Systematic Review and Meta-analysis
A systematic review and meta-analysis evaluating the effects of early-life polyunsaturated fatty acids and trans fatty acids on atopic derma…
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases [NA]
This clinical-trial update reviews the mechanisms by which phototherapy and photochemotherapy exert therapeutic effects in skin diseases. It…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema [Phase 3]
Phase 3 trial update on efficacy and safety of a retinoid for severe chronic hand eczema; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Black Tea Compresses for Facial Eczema and Perioral Dermatitis [NA]
A completed clinical trial evaluated the use of black tea compresses for facial eczema and perioral dermatitis.
-
FDA approval · 2017-10-27FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for a generic clobetasol propionate topical product from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2017-10-25FDA Approved: CLOBETASOL PROPIONATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for clobetasol propionate from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial update showing dupilumab demonstrates efficacy and long-term safety in adults with moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo [Phase 2]
A Phase 2 study evaluated two topical doses of GW870086X against a positive control and placebo in atopic dermatitis; results were posted in…
-
FDA approval · 2017-10-16FDA Approved: EUCRISA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for EUCRISA (crisaborole) submitted by Pfizer Laboratories Div Pfizer Inc. This approval represents …
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial update for dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD) [Phase 2]
Phase 2 study assessing the safety of dupilumab (REGN668/SAR231893) given with topical corticosteroids in adults with moderate-to-severe ato…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis [EARLY_Phase 1]
An early-phase exploratory study evaluating cutaneous penetration of biodegradable polymeric microparticles in patients with atopic dermatit…